Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-034

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70594-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daptomycin 01)

Chemical structure diagram of daptomycin, showing its molecular configuration with labeled functional groups and bonds as a complex peptide antibiotic.*

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Daptomycin for Injection 500 mg/vial lyophilized powder for intravenous infusion in a carton packaging label. The label includes instructions to reconstitute with 10 mL 0.9% Sodium Chloride Injection to achieve 50 mg/mL. The product must be refrigerated at 2°C to 8°C and contains no preservatives. Manufactured for Xellia Pharmaceuticals USA LLC, made in India. Includes barcode and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.